Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
shares in Thousands, $ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 63,956 $ 82,585
Deposits Assets, Current 80,000 80,000
Accounts Receivable, after Allowance for Credit Loss, Current 153,653 172,009
Inventories 195,188 192,976
Prepaid expenses 8,522 7,929
Other current assets 18,025 24,596
Total current assets 519,344 560,095
Non-current assets    
Property, plant and equipment, net 183,969 197,552
Goodwill 100,086 100,051
Other intangible assets, net 111,883 127,781
Operating lease right-of-use assets 32,591 18,895
Long-term investments 120,070 115,083
Other non-current assets 14,734 14,448
Total non-current assets 563,333 573,810
Total assets 1,082,677 1,133,905
Current liabilities    
Accounts payable 48,157 46,785
Accrued expenses and other current liabilities 35,328 36,656
Employee related charges 29,428 33,877
Deferred revenues - short-term 49,788 52,610
Operating lease liabilities - short term 6,714 6,498
Total current liabilities 169,415 176,426
Non-current liabilities    
Deferred revenues - long-term 19,109 23,655
Deferred income taxes 574 723
Operating lease liabilities - long term 25,420 12,162
Contingent consideration 12,410 11,900
Other non-current liabilities 23,971 24,200
Total non-current liabilities 81,484 72,640
Total liabilities $ 250,899 249,066
Commitments and Contingencies Disclosure [Abstract]    
Ordinary shares, authorized 180,000  
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 shares; 67,086 shares and 65,677 shares issued and outstanding at December 31, 2022 and 2021, respectively $ 200 195
Additional paid-in capital 3,117,626 3,091,649
Accumulated other comprehensive loss (7,782) (7,079)
Accumulated deficit (2,278,266) (2,199,926)
Total equity 831,778 884,839
Total liabilities and equity $ 1,082,677 $ 1,133,905